STING1 and small cell lung carcinoma: Interestingly, in three different SCLC cell lines (H82, H526 and H1048) wherein STING and cGAS genes are expressed, PARP inhibitors were shown to increase the cellular levels of IFN-B gene mRNA along with activated pathway factors such as pSTING_S366 and cGAS [44].